In particular, CP-31398 has been shown to effectively reduce tumor initiation and progression using cultured human cells in vitro, including germ line p53 deficient Li – Fraumeni syndrome (LFS) cells and primary mouse tumor model systems in vivo [28–31]. The gene discussed is TP53; the disease is neoplasm.